Thursday, July 20, 2017

PUTTING A PERSPECTIVE ON JUST HOW LARGE THE KHADR SETTLEMENT IS

The pharmaceutical giant behind the blockbuster pain pill that triggered Canada’s deadly opioid crisis has agreed to pay $20-million to settle a long-standing class-action lawsuit.
The proposed national settlement caps a legal battle that began a decade ago between Purdue Pharma, the maker of OxyContin, and lawyers representing as many as 2,000 Canadians who got hooked on the drug after their doctors prescribed it. The country’s opioid epidemic traces its roots to the introduction of the prescription painkiller 21 years ago. From 2000 to 2015, more than 6,300 died in Ontario alone from overdoses related to opioids.

No comments:

Post a Comment